• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Amarin Corp ADR (NQ: AMRN )

    0.8838 +0.0138 (+1.59%)
    Streaming Delayed Price Updated: 1:57 PM EDT, Apr 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 502,087
    Open 0.8700
    Bid (Size) 0.8838 (3)
    Ask (Size) 0.8839 (1)
    Prev. Close 0.8700
    Today's Range 0.8600 - 0.8848
    52wk Range 0.6510 - 1.485
    Shares Outstanding 407,265,944
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
    Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanism of Action 
    From Amarin Corporation plc
    Via GlobeNewswire

    Performance

    YTD
    -0.61%
    -0.61%
    1 Month
    +1.88%
    +1.88%
    3 Month
    -18.92%
    -18.92%
    6 Month
    +19.84%
    +19.84%
    1 Year
    -36.87%
    -36.87%

    More News

    Read More
    New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
    From Amarin Corporation plc
    Via GlobeNewswire
    Earnings Scheduled For February 29, 2024
    Via Benzinga
    Why Amarin Stock Skyrocketed Today
    Via The Motley Fool
    Why Pharma Company Amarin Shares Are Zooming Today
    Via Benzinga
    Why Amarin Stock Was Rocketing Higher on Wednesday
    Via The Motley Fool
    Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
    From Amarin Corporation plc
    Via GlobeNewswire
    Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Is Amarin Stock Trading Lower After Q4 Earnings?
    Via Benzinga
    Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin Chairman & CEO Issue Letter to Shareholders
    From Amarin Corporation plc
    Via GlobeNewswire
    Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Crude Oil Falls 1%; Amarin Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    What's Going On With Amarin Stock?
    Via Benzinga
    Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Amarin Corporation plc
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.